BUPIVACAINE HYDROCHLORIDE INJECTION, USP

baxter corporation🇨🇦 Health Canada

Approval Id: 9bac2bfc79a166b1
Drug Approval Canada Name: BUPIVACAINE HYDROCHLORIDE INJECTION, USP
Product Name: BUPIVACAINE HYDROCHLORIDE INJECTION, USP
Status: Marketed
Status Date: 2022-08-15
Original Market Date: 2022-08-15
Din: 02488930
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Epidural , Retrobulbar
Schedule: Ethical
Ahfs: 72:00.00
Atc Original: N01BB01 BUPIVACAINE
Atc Name: n 01 bb 01
Aig Number: 0108896002
Company Name: baxter corporation
Company Address: 7125 Mississauga Road, Mississauga, Ontario, Canada, L5N 0C2

BUPIVACAINE HYDROCHLORIDE

7.5 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

9bac2bfc79a166b1

Type

Standard